30.20BMarket Cap-15.14P/E (TTM)
27.700High26.550Low5.51MVolume27.500Open27.900Pre Close149.63MTurnover0.50%Turnover RatioLossP/E (Static)1.10BShares28.95052wk High4.63P/B30.20BFloat Cap10.56052wk Low--Dividend TTM1.10BShs Float151.200Historical High--Dividend LFY4.12%Amplitude10.560Historical Low27.164Avg Price100Lot Size--Div YieldTTM--Div Yield LFY
ZAI LAB Stock Forum
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) has received Orphan Drug Designation (ODD) from the U.S. FDA for ZL-1310, their first-in-class DLL3 antibody-drug conjugate (ADC) designed to treat small cell lung cancer (SCLC). The designation comes after promising results from an ongoing Phase 1a/1b study in patients with previously treated extensive-stage SCL...
No comment yet